Thursday, 7 April 2022

Dr. Rajan Mahtani Conferred With Forbes Philanthropy Awards

 


Dr. Rajan Lekhraj Mahtani is one of the most reputable and well-known businessmen from Zambia. He is the proprietor and chief of top Zambian corporations such as Mahtani Group of Companies, Finsbury Investments, Finance Bank Zambia, and several others. Recently, Dr. Rajan Mahtani changed into conferred with the distinguished Forbes ‘Best of Africa’ award. This is the world over recognised award that's given to pinnacle leaders and businessmen with massive contributions for empowerment and improvement of the African continent. The award holds huge value as awardees are selected from whole African continent. Dr. Rajan Lekhraj Mahtani become bestowed with the ‘Outstanding Entrepreneur of the Year’ award 2021 for his significant have an effect on toward redefining the banking enterprise of Zambia. Dr. Rajan Mahtani’s top business enterprise is Mahtani Group which was established in 1981. In a brief span of time, the organisation extended its marketplace from Zambia to South Africa, Malawi in addition to worldwide locations along with United Kingdom. The company further expanded its operations to numerous sectors which include insurance and monetary offerings, real estate, power, agriculture, and mining.

On the alternative hand, the philanthropic and charitable contributions from Dr. Rajan Mahtani are lesser recognised because of lack of promotions. He is the founder & proprietor of Prison Fellowship Zambia, a first-rate software which focusses on welfare of the inmates, ex-inmates their households in addition to recommended fair and obvious crook justice method. He additionally contributed to training area of Zambia via organising Stephen Malama award, which gives scholarships to pinnacle law graduates in conjunction with financial help.

Thankfully, Forbes identified these giant contributions from Dr. Mahtani and rightly conferred him with the ‘Outstanding Entrepreneur of the Year award’ 2021 at some stage in the roundtable convention.

No comments:

Post a Comment